{"title":"研究发现加巴喷丁类药物不会增加自残的风险","authors":"","doi":"10.1002/pu.31344","DOIUrl":null,"url":null,"abstract":"<p>A population-based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self-harm during treatment. Risk of self-harm was elevated during pre- and post-treatment periods, the investigators found. Study results were published online April 30, 2025 in <i>The BMJ</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 9","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Study finds gabapentinoid treatment does not elevate risk of self-harm\",\"authors\":\"\",\"doi\":\"10.1002/pu.31344\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A population-based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self-harm during treatment. Risk of self-harm was elevated during pre- and post-treatment periods, the investigators found. Study results were published online April 30, 2025 in <i>The BMJ</i>.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"36 9\",\"pages\":\"1-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31344\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31344","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Study finds gabapentinoid treatment does not elevate risk of self-harm
A population-based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self-harm during treatment. Risk of self-harm was elevated during pre- and post-treatment periods, the investigators found. Study results were published online April 30, 2025 in The BMJ.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
